PMID: 11907186Mar 22, 2002Paper

Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins

The Journal of Pharmacology and Experimental Therapeutics
Hiroaki KimuraHitoshi Endou

Abstract

Prostaglandin E(2) (PGE(2)) and prostaglandin F(2 alpha) (PGF(2 alpha)) have been used for the induction of labor and the termination of pregnancy. Renal excretion is shown to be an important pathway for the elimination of PGE(2) and PGF(2 alpha). The purpose of this study was to elucidate the molecular mechanism of renal PGE(2) and PGF(2 alpha) transport using cells stably expressing human organic anion transporter (hOAT) 1, hOAT2, hOAT3, and hOAT4, and human organic cation transporter (hOCT) 1 and hOCT2. A time- and dose-dependent increase in PGE(2) and PGF(2 alpha) uptake was observed in cells expressing hOAT1, hOAT2, hOAT3, hOAT4, hOCT1, and hOCT2. The K(m) values of PGE(2) uptake by hOAT1, hOAT2, hOAT3, hOAT4, hOCT1, and hOCT2 were 970, 713, 345, 154, 657, and 28.9 nM, respectively, whereas those of PGF(2 alpha) uptake by hOAT1, hOAT3, hOAT4, hOCT1, and hOCT2 were 575, 1092, 692, 477, and 334 nM, respectively. PGE(2) and PGF(2 alpha) significantly inhibited organic anion uptake by hOATs and organic cation uptake by hOCTs. In conclusion, considering the localization of these transporters, the results suggest that PGE(2) and PGF(2 alpha) transport in the basolateral membrane of the proximal tubule is mediated by multiple pat...Continue Reading

References

Sep 1, 1976·European Journal of Pharmacology·A G Herman, J R Vane
Jan 1, 1986·Kidney International·D Schlondorff, R Ardaillou
Jun 8, 1973·Biochemical and Biophysical Research Communications·C A Leslie, L Levine
Jan 4, 1994·Proceedings of the National Academy of Sciences of the United States of America·E JacqueminP J Meier
Oct 1, 1993·Physiological Reviews·J B Pritchard, D S Miller
Jul 16, 1996·Biochemical and Biophysical Research Communications·M OkudaK Inui
Jul 25, 1997·The Journal of Biological Chemistry·T SekineH Endou
Jul 1, 1997·DNA and Cell Biology·V GorboulevH Koepsell
Dec 31, 1997·The Journal of Biological Chemistry·D H SweetJ B Pritchard
Mar 29, 2000·Biochemical and Biophysical Research Communications·H UchinoA Tsuji
Jul 12, 2001·The Journal of Biological Chemistry·G PietigE Schlatter
Feb 28, 2002·The Journal of Pharmacology and Experimental Therapeutics·Michio TakedaHitoshi Endou
Jun 14, 2002·Biochimica Et Biophysica Acta·Ellappan BabuHitoshi Endou

❮ Previous
Next ❯

Citations

Oct 8, 2005·Naunyn-Schmiedeberg's Archives of Pharmacology·Stephanie HarlfingerDirk Gründemann
Feb 3, 2005·Pflügers Archiv : European journal of physiology·Giuliano Ciarimboli, Eberhard Schlatter
Jan 25, 2007·Pharmaceutical Research·Ahsan N Rizwan, Gerhard Burckhardt
Mar 26, 2003·European Journal of Pharmacology·Suparat KhamdangHitoshi Endou
Apr 8, 2003·European Journal of Pharmacology·Atsushi EnomotoHitoshi Endou
May 3, 2005·Pharmacogenetics and Genomics·Tomoe FujitaKathleen M Giacomini
Jul 30, 2010·American Journal of Physiology. Renal Physiology·James E ShimaKathleen M Giacomini
Oct 4, 2011·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Yasuna KobayashiToshinori Yamamoto
Nov 11, 2003·Clinical Pharmacokinetics·Susan E TettAndrew J McLachlan
Jul 2, 2003·Proceedings of the National Academy of Sciences of the United States of America·Glen ReidPiet Borst
Jul 25, 2006·Expert Opinion on Drug Metabolism & Toxicology·Meng LiJoanne Wang
Nov 25, 2005·Journal of Pharmaceutical Sciences·Tomoe FujitaKathleen M Giacomini
Aug 1, 2008·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·G Ciarimboli
May 20, 2003·Kidney International·Merlin C ThomasPhillip Kantharidis
Dec 23, 2015·Prostaglandins & Other Lipid Mediators·Tomoka GoseIkumi Tamai
Jul 31, 2012·Pharmacology & Therapeutics·Gerhard Burckhardt
Dec 3, 2009·Biopharmaceutics & Drug Disposition·Adam L VanWertDouglas H Sweet
Jun 29, 2004·Trends in Pharmacological Sciences·Hermann Koepsell
Nov 19, 2005·European Journal of Pharmacology·Junya NagaiMikihisa Takano
Sep 15, 2005·Biochemical and Biophysical Research Communications·Madoka SakuraiKikuko Watanabe
Apr 18, 2008·European Journal of Pharmacology·Azza A K El-SheikhFrans G M Russel
Nov 27, 2014·Frontiers in Pharmacology·Darren M MossAndrew Owen
Dec 6, 2014·Nature Reviews. Drug Discovery·Sanjay K Nigam
Jan 16, 2007·Journal of Pharmacological Sciences·Sirinun NilwarangkoonHitoshi Endou
Feb 24, 2004·Journal of Pharmacological Sciences·Suparat KhamdangHitoshi Endou
Jun 21, 2016·Advanced Drug Delivery Reviews·Fanfan ZhouMichael Murray
Oct 27, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·David HahnTsuyoshi Fukuda
Feb 24, 2017·Journal of Medicinal Chemistry·Eugene C ChenKathleen M Giacomini
Apr 17, 2018·Journal of Personalized Medicine·Elisa LozanoElisa Herraez
Dec 1, 2017·Scientific Reports·Takeo NakanishiIkumi Tamai
Jul 9, 2004·American Journal of Physiology. Renal Physiology·S SoodvilaiW H Dantzler
Jul 23, 2004·Physiological Reviews·Stephen H Wright, William H Dantzler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved